Clinical Trial Update: Immunogenicity and Tolerability Study of Fluval AB Novo Suspension for Injection for Children and Adolescents [Phase 3]

View source ↗

Summary

Phase 3 trial update on immunogenicity and tolerability of Fluval AB Novo Suspension for Injection in children and adolescents with human influenza completed wi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Human Influenza

Drugs mentioned

• Fluval AB Novo Suspension for Injection

Snippet

Sponsor: Fluart Innovative Vaccine Ltd, Hungary | Conditions: Human Influenza | Phase 3 | Status: COMPLETED | Results posted: 2021-03-11